Parameter
| Biomarker | p-ERK1/2 | Full name | Phosphorylated extracellular signal-regulated kinase 1/2 | Molecular Type | protein |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | ERK1:44 kDa; ERK2:42 kDa | Core Functional Dimensions | Therapeutic targets | |
| Disease | Angiosarcoma | Disease Subtypes | / | ||
| Organ | Tumor cells | Test Sample / Technology Platform | Organization (IHC) | ||
| Pathobiological Mechanisms | MAPK/ERK pathway activation markers, promote cell proliferation and survival | ||||
| Clinical Availability Status | Validation: subtypes heterogeneity expression | ||||
| Notes and Dynamics | Expression rate of 54% (31% 95%), and provide the basis for MEK inhibitor treatment | ||||